Top 50 Health Care Startup Investors in Israel (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Pontifax
VC Fund
|
23 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.8M–$100M |
|
OurCrowd
VC Fund
|
18 | Israel, United States, Canada | Series B, Series A, Seed | Software, Artificial Intelligence, Machine Learning | $1.1M–$60M |
|
Trendlines Group
VC Fund
|
17 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $500k–$7.5M |
|
Israel Innovation Authority
VC Fund
|
14 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Medical Device, Software | $91k–$4M |
|
Accelmed
VC Fund
|
11 | Israel, United States | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
Triventures
VC Fund
|
9 | United States, Israel, Ireland | Series B, Seed | Health Care, Medical Device, Medical | $1M–$50M |
|
OrbiMed
VC Fund
|
9 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $10M–$120M |
|
Vertex Ventures Israel
VC Fund
|
8 | Israel, United States, Canada | Series B, Series A, Series C | Software, Information Technology, Artificial Intelligence | $3M–$100M |
|
Docor International Management
VC Fund
|
7 | Israel, United States | Series C, Series A | Health Care, Biotechnology, Pharmaceutical | $13M–$22M |
|
Firstime Venture Capital
VC Fund
|
7 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $500k–$19M |
|
Agriline
VC Fund
|
6 | Israel | Series A, Seed | Health Care, Medical Device, AgTech | |
|
HBL Hadasit Bio Holdings
VC Fund
|
6 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
Pitango VC
VC Fund
|
6 | Israel, United States, China | Series A, Series B, Series C | Software, Health Care, Information Technology | $2M–$42M |
|
Elron Ventures
VC Fund
|
6 | Israel, United States, China | Seed, Series A | Information Technology, Health Care, Software | $600k–$8M |
|
SeedIL Ventures
VC Fund
|
6 | Israel, United Kingdom, Australia | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Big Data | $1.7M–$21M |
|
aMoon Fund
VC Fund
|
6 | United States, Israel, United Kingdom | Series A, Series B | Biotechnology, Health Care, Medical | $6M–$63M |
|
Arkin Holdings
VC Fund
|
5 | Israel, United States, Switzerland | Series A, Seed | Biotechnology, Health Care, Medical Device | $5.5M–$20M |
|
Sapir Venture Partners
VC Fund
|
5 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Machine Learning | $1.3M–$5M |
|
Marius Nacht
Angel
|
5 | Israel, United States, Switzerland | Series A, Seed, Series B | Artificial Intelligence, Machine Learning, Health Care | $5.3M–$120M |
|
J-Ventures
VC Fund
|
5 | United States, Israel | Seed, Series A, Pre-Seed | Health Care, Software, Machine Learning | $2.5M–$20M |
|
Integra Holdings
VC Fund
|
5 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
Clal Biotechnology Industries
VC Fund
|
5 | Israel, United States | Series A, Series B | Biotechnology, Health Care, Medical | $4M–$55M |
|
Entrée Capital
VC Fund
|
5 | United States, Israel, United Kingdom | Seed, Series A, Series B | Software, Financial Services, FinTech | $1M–$50M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
5 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$80M |
|
Terra Venture Partners
VC Fund
|
4 | Israel, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $1M–$14M |
|
Tal Ventures
VC Fund
|
4 | Israel, United States, Cyprus | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $2.5M–$120M |
|
Sanara Ventures
VC Fund
|
4 | Israel | Seed, Series A | Health Care, Medical, Medical Device | $800k–$6M |
|
TAU Ventures
VC Fund
|
4 | Israel, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $1M–$16M |
|
Connecticut Innovations
VC Fund
|
4 | United States, Israel, Canada | Series A, Seed | Health Care, Biotechnology, Software | $150k–$25M |
|
Grove Ventures
VC Fund
|
4 | Israel, United States | Seed, Series A, Series B | Artificial Intelligence, Machine Learning, Software | $3.3M–$74M |
|
NextLeap Ventures
VC Fund
|
4 | Israel, United States | Seed, Series A | Software, Big Data, Health Care | $900k–$5M |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | $3.5M–$23M |
|
Good Seed Ventures
VC Fund
|
4 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $2M–$3M |
|
LionBird
VC Fund
|
4 | United States, Israel, India | Seed, Series A, Series B | Health Care, Software, Artificial Intelligence | $1.1M–$100M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
4 | Israel, United States | Series A, Series B | Health Care, Medical, Biotechnology | $4.4M–$8.4M |
|
The Chartered Group
VC Fund
|
4 | Israel | Series A, Private Equity | Biopharma, Agriculture, Health Care | |
|
Hanaco Venture Capital
VC Fund
|
4 | United States, Israel, Germany | Series A, Seed, Series C | Software, Financial Services, FinTech | $2.5M–$70M |
|
Takeda Ventures
VC Fund
|
4 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $8M–$100M |
|
Qure Ventures
VC Fund
|
3 | United States, Israel | Series A, Series B, Series C | Health Care, Medical Device, Medical | $11M–$20M |
|
Maniv Mobility
VC Fund
|
3 | Israel, United States, Mexico | Series A, Seed, Series B | Automotive, Autonomous Vehicles, Software | $2M–$126M |
|
Chartered Opus
VC Fund
|
3 | Israel | Series A | Wellness, Biotechnology, Manufacturing | $3M–$3.5M |
|
SciSparc
VC Fund
|
3 | Israel | Corporate Round | Pharmaceutical, Cannabis, Biopharma | $400k–$700k |
|
Ran Tuttnauer
Angel
|
3 | Israel, Canada, United States | Seed, Series A | Health Care, Big Data, Medical Device | |
|
PipelBiz.com
VC Fund
|
3 | Israel, United States, United Kingdom | Equity Crowdfunding, Seed | Software, Health Care, Manufacturing | $152k–$1M |
|
Aleph
VC Fund
|
3 | United States, Israel, China | Seed, Series A, Series B | Software, SaaS, Analytics | $2.4M–$50M |
|
TechWald Holding S.p.A.
VC Fund
|
3 | Israel, United States | Series A, Series B, Series C | Health Care, Medical, Medical Device | |
|
fresh.fund
VC Fund
|
3 | Israel, United States, Norway | Pre-Seed, Seed, Series A | Health Care, FinTech, E-Learning | $300k–$8M |
|
Boston Scientific
VC Fund
|
3 | United States, Israel, Canada | Series B, Series C | Health Care, Medical Device, Biotechnology | $3M–$23M |
|
FutuRx
VC Fund
|
3 | Israel | Health Care, Biotechnology, Pharmaceutical | ||
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
| Access all 722 investors in Israel Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 93
- Round size: Series A $3.8M–$72M; Series B $16M–$100M; Series C $12M–$75M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
- ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Access exclusive VC angel investment deals in pre-vetted startup companies. Join now.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 240
- Round size: Seed $1.1M–$8M; Series A $3.5M–$15M; Series B $6M–$60M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- ThetaRay — ThetaRay's big data analytics solutions are based on AI & machine learning, empowering businesses to find opportunities and threats hidden in their big data
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Intuition Robotics — Intuition Robotics empowers older adults to live happier, healthier and independent lives at home with an empathetic digital companion, ElliQ.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 56
- Round size: Seed $500k–$3M; Series A $2.3M–$7.5M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
- Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
- PlanetWatchers — Highly accurate crop growth, wind, hail and flood damage assessments at scale. Supporting the crop insurance industry with acreage and claims validation.
The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 107
- Round size: Seed $500k–$4M; Grant $91k–$2.5M; Pre-Seed $150k–$1M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- BloomX — Helping nature do its magic with the power of technology
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 34
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
- Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
- Click Therapeutics — A biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Learn more.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Seed
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 42
- Round size: Seed $1M–$10M; Series B $6M–$50M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 419
- Round size: Series A $10M–$102M; Series B $23M–$120M; Series C $12M–$108M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
- Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
- Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
We partner early with global-minded entrepreneurs seeking to disrupt large markets
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series B, Series A, Series C
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 158
- Round size: Series A $3M–$22M; Series B $3M–$33M; Series C $3.6M–$100M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $70M in 2018
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- Unity SCM — Data across your entire supply chain easily collected and organized in one place
- Trigo Vision — Trigo tech-powers grocery stores with market leading touch-free checkout and digitized operations. AI-driven and fully automated, our proven solution layers digital commerce capabilities onto existing spaces with zero downtime to business.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Firstime Ventures is investing in companies who are building a sustainable & accessible future for all.
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 78
- Round size: Seed $600k–$6M; Series A $500k–$10M; Series B $17M–$19M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — raised $50M in 2017
Portfolio highlights
- Pixellot — Pixellot is a leading sport media company that offers automatic production solutions for the amateur and semi-professional market. Pixellot’s patented technology streamlines the production workflow by deploying an unmanned multi-camera system that covers the entire field. Advanced algorithms enable dynamic coverage of the flow of play and highlightgeneration. The company streams more than 11,000 live video hours each month to fans, players, and coaches on a variety of platforms. Founded in 2013 by seasoned video and media technology experts, Pixellot has sold over 2,000 systems around the world, deployed with minor leagues, high schools, as well as at youth academies and top league clubs. Pixellot’s partners include ESPN, PlayOn Sports, the US’ biggest high school sports media company and right holder, Sporttotal.tv, Germany’s largest amateur league media platform, global coaching solution provider STATS, SeeUPlay in Mexico and Hockey TV, North America’s largest non-NHL ice hockey streaming platform. The company also works directly with leading clubs such as Bayern Munich, Spain’s Real Sociedad, Dutch AZ Alkmaar and Maccabi Tel-Aviv.
- Securithings — Bringing IT Standards to the IoT Space.
- Maverick Medical AI — Maverick Medical AI Deep Learning Autonomous Medical Coding Platform with guaranteed 85% Direct-to-Bill rate upon go live with 97% accuracy
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical Device, AgTech
- Stage:Series A, Seed
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- FruitSpec — FruitSpec provides customers with the ability to manage their yield, using accurate yield estimation solution.
- Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, China
Investor stats
- Total investments: 243
- Round size: Series A $2M–$25M; Series B $7M–$35M; Series C $7.5M–$42M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- AI21 Labs — AI21 Labs is an AI lab & product company whose mission is to reimagine the way we read and write by making the machine a thought partner to humans.
- QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Health Care, Software
- Stage:Seed, Series A
- Geography: Israel, United States, China
Investor stats
- Total investments: 59
- Round size: Seed $600k–$6.5M; Series A $1M–$8M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Creednz — B2B Payments Protection using internal finance data enriched w/ externally curated intelligence, enabling informed payment decisions in RT.
- Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
- Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.
SeedIL Ventures is a seed stage investment fund focusing on Israeli related companies in any sector except medtech/biotech and heavy Hardware. After investment, SeedIL is committed to ensuring that portfolio companies reach their full potential by providing on-going coaching and connections through its extensive network, including the Limitedpartner's connections and intelligence.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Big Data
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United Kingdom, Australia
Investor stats
- Total investments: 28
- Round size: Seed $1.7M–$6.5M; Series A $2.2M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Wisor — Propelling the supply chain industry into the digital age Wisor is a plug & play solution that provides a global automated quoting solution that allows freight forwarders to generate quotes and communicate with clients automatically Get a demo What took days now takes minutes Wisor is specifically designed to support and simplify the complexity of generating quotes
- Konnecto — Market Intelligence | Konnecto | Prescriptive Analytics Konnecto is a GTM Intelligence Platform that provides brands with an ongoing blueprint on how to increase online sales and improve marketing ROI
- myInterview — Hire the right candidates with myInterview with Video for Free. Create Your Account Today. The Video Tool Recruiters Love.
aMoon is a leading healthtech & life sciences venture capital firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 49
- Round size: Series A $6M–$63M; Series B $30M–$35M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $7.3M in 2019
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Eleos Health — Eleos Health provides automated health tech solutions that accelerate clinicians’ decision-making via an AI-powered Speech-to-Insights system to ensure the provision of personalized and time and cost-effective care.
- Ultima Genomics — Ultima Genomics, Inc is revolutionizing DNA sequencing technology with the UG100 by providing scalability for the $100 genome
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 21
- Round size: Seed $5.5M–$6M; Series A $18M–$20M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $1.3M–$5M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
- Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987.
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Health Care
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 32
- Round size: Seed $10M–$120M; Series A $5.3M–$17M; Series B $8M–$74M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Wisdo Health — Our award-winning social health platform utilizes SDOH assessments and pro-social measures to increase quality of life and decrease medical spending.
- WaveBL — WAVE BL lets you digitally issue, transfer, sign, endorse and surrender trade documents while cutting costs and eliminating fraud.
- CommonGround-AI — We provide a software solution that delivers the benefits of face to face plus a whole lot more.
J- Ventures is a Silicon Valley based group of VC funds with over $60m under management. Backed by 400+ leading Investors ( 140+ Serial founders, 100+ VCs, 170+ Fortune 500 Executives) as LPs. Our active-LP venture fund brings the power of this connected & intellectual capital to add real value to the companies we invest in and create aremarkable difference by helping our founders grow and scale to markets quicker. Based in Silicon Valley with investors from 15 communities - Tel Aviv, NYC, LA, London, Miami, Boston, and more. Since 2016 the group made over 50 investments, 4 unicorns and over 10 exits.
Show more...Investment focus
- Industry: Health Care, Software, Machine Learning
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 50
- Round size: Seed $2.5M–$4.7M; Series A $5.5M–$20M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Joylux — We offer innovative women's intimate care products, which can be used in the comfort of home. Take the first step on your wellness journey today & shop now!
- BeeHero — BeeHero - Your precision pollination provider for almonds, berries, apples and more We raise and keep exceptional bees by combining generations of commercial beekeeping experience with cutting-edge technology. Get premium bees & pollinate your crops with precision.
- Onebeat — Onebeat is one of the most exciting retail-tech solutions today. We specialize in adaptive inventory management at scale, item by item.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series A $4M–$55M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
We're a team of former serial founders managing over $1B across a number of funds, with offices in Tel Aviv, London, and New York.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 203
- Round size: Seed $1M–$12M; Series A $3.7M–$25M; Series B $7.8M–$50M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cypago — End-to-end intelligent compliance solution for any security standard including SOC 2, ISO 27001, SOX-ITGC, and HIPAA
- Swapp — Real estate developers, architects and engineers use Swapp to design buildings in a smart, flexible and efficient process.
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 69
- Round size: Series A $5.9M–$65M; Series B $7.5M–$80M; Series C $300k–$70M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
- ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
- Nucleome Therapeutics — Decoding the dark matter of the human genome to deliver first-in-class precision medicinesDiscover More
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 34
- Round size: Seed $1M–$3.5M; Series A $2.1M–$14M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- FieldIn — Fieldin delivers risk mitigation for high value crops, helping farmers stay competitive against shrinking prices and profits.
- Arugga AI Farming — Arugga intends to transform greenhouse vegetable farming into a data-driven, automated and efficient field by designing the first autonomous robot which will monitor and treat every individual plant in the greenhouse.
- Intuition Robotics — Intuition Robotics empowers older adults to live happier, healthier and independent lives at home with an empathetic digital companion, ElliQ.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 36
- Round size: Seed $2.5M–$15M; Series A $10M–$20M; Series B $35M–$120M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Atly — Skip the hunt. Find the best restaurants, date spots, hiking trails and more through groups of people who share your interests.
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Cyclops Security — stealth mode.
Sanara Ventures is an innovation-investment platform, elevating outstanding healthcare-technology companies, from early-stage to global market maturity. At Sanara, They share a vision of an integrated continuum of care supported by accessible advanced healthcare solutions for people around the world.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 6
- Round size: Seed $800k–$2.7M; Series A $4M–$6M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- QTflow Ltd. — A Micro Air Pump Technology: The Future of Thermal Management
- CVAid Medical — CVAid Medical develops an innovative AI based stroke detection technological platform.
- TailorMed — Moving Mountains for Patients
TAU Ventures is an early-stage focused venture capital fund affiliated with Tel Aviv University, investing in the next generation of impactful home-grown technology companies. At the heart of the start-up nation, TAU Ventures invests the first capital into startups and is dedicated to helping them transform their ideas into global businesses.TAU Ventures cultivates an innovation ecosystem by combining the resources and global network of Tel Aviv University, strong industry connections, and a supportive home-base for founders. Together with its world-leading team of experienced mentors, TAU Ventures empowers startups in their critical, early steps. At its 1000 sq meter co-working office space located in Tel Aviv, the team works shoulder to shoulder with their portfolio companies, nurturing their growth by drawing on the strength of its innovation ecosystem on a daily basis.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 34
- Round size: Seed $1M–$5.3M; Series A $9M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely still investing — raised $50M in 2021
Portfolio highlights
- TaTiO — TaTIO is delivering a smarter way to hire through competency-based sourcing that combines artificial intelligence and job experience simulations to guarantee qualified candidates.
- Cerby — Collaborate without chaos. Cerby helps your team be productive while protecting your brand. Secure unmanageable applications. Only with Cerby.
- InnerPlant — InnerPlant transforms fields into living sensors with biotech, remote sensing, and data science. We enable plants to express stress within hours of emergence.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 211
- Round size: Seed $150k–$2.3M; Series A $1.8M–$25M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- OOVA — OOVA is a fertility diagnostic company that spun out from Mount Sinai Hospital in New York City. Using patent pending biochemistry and artificial intelligence, OOVA learns a woman’s fertility profile by accurately measuring key hormones over time through daily urine samples. By monitoring this critical balance of hormones, OOVA can help a woman getpregnant, identify reasons she is having trouble getting pregnant, and even expose reproductive health issues like PCOS.
- Raise Green — Raise Green is the climate tech marketplace for local impact investing licensed with the SEC and FINRA to sell private securities.
- Driver Technologies — Turn your phone into a dash cam.
Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Software
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 45
- Round size: Seed $3.3M–$9M; Series A $5.5M–$23M; Series B $25M–$74M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
- DeepChecks — Continuous validation for machine learning. Validate and monitor your data and models during training, production and new version releases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.
Show more...Investment focus
- Industry: Software, Big Data, Health Care
- Stage:Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Seed $900k–$5M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Cybord — Cybord develops technologies that stop counterfeit, defective and malicious electronic components from getting assembled into products during the manufacturing process. Cybord scans each component prior to placement by integrating with electronic product manufacturing equipment, and deep learning algorithms rate each component based on Cybord’sglobal component database. Between 5 to 10% of all electronic components are considered counterfeit, responsible for up to 35% of RMAs. With Cybord, OEMs, EMSs, and distributors ensure their products are of high quality and free of hardware-cyber threats
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- ShieldIOT — ShieldIOT delivers innovative cybersecurity solutions that protect edge devices from security threats and operational risks. Their application-agnostic software solution enables device manufacturers and network operators to automatically secure existing and new devices, across multiple industries, with no need for any development resources orsecurity expertise.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Round size: Series A $3.5M–$23M
- Lead/follow: 76% lead, 24% follow
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 27
- Round size: Seed $2M–$3M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Perfeggt — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
- Nosh Biofoods — Nosh Biofoods is a developer of traditional meat.It produces technical-functional components and nutritional protein by utilising manufacturing technologies to explore natural microbial biodiversity.
LionBird is a Tel Aviv- and Chicago-based venture capital firm investing in early-stage software companies operating in the healthcare, commerce, and enterprise sectors. Founded in 2012, LionBird has developed an investment strategy around early-stage startups that leverages online technology to re-imagine traditional offline business processes andmodels.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, India
Investor stats
- Total investments: 54
- Round size: Seed $1.1M–$6.6M; Series A $3M–$18M; Series B $6.5M–$100M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $85M in 2022
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Rhino Health — Rhino Health utilizes Federated Learning to improve healthcare AI solutions by providing access to a large, continually updated, distributed dataset from a diverse group of patients, powering AI models that deliver consistent results and improve the standard of care.
- Nest Genomics (YC W22) — Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 11
- Round size: Series A $4.4M–$8.4M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- Append Medical — Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growingsegment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
The Chartered Group is an investment platform.
Show more...Investment focus
- Industry: Biopharma, Agriculture, Health Care
- Stage:Series A, Private Equity
- Geography: Israel
Investor stats
- Total investments: 4
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
- Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.
Hanaco Ventures backs early-stage technology companies with visionary and passionate entrepreneurs. Hanaco was founded by Alon Lifshitz, Lior Prosor, and Pasha Romanovski in 2017 and is headquartered in Tel Aviv, Israel.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Series A, Seed, Series C
- Geography: United States, Israel, Germany
Investor stats
- Total investments: 71
- Round size: Seed $2.5M–$9M; Series A $4M–$23M; Series C $40M–$70M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- UVeye — UVeye is the leading automatic vehicle inspection provider, offering coverage throughout the vehicle lifecycle. Backed by GM, CarMax, Volvo, Toyota & Hyundai.
- Chain Reaction — Chain Reaction is engineering the future of disruptive blockchain and privacy technologies by accelerating compute and mining hardware performance.
- Hyro — A stellar customer journey starts with conversational AI. Take complex data and turn it into simple dialogue across any digital channel, for all enterprises and their customers.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 95
- Round size: Series A $8M–$43M; Series B $11M–$100M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 8
- Round size: Series A $11M–$20M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- CoreMap — CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
- Sweetch — Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabeticpopulation, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change.Sweetch developed a proprietary machine-learning platform that predicts an individual’s 3-year risk for developing Metabolic Syndrome related diseases – type 2 diabetes, hypertension, hyperlipidemia, and obesity.
- Carevive Systems — Powered by real world patient experience data, Carevive builds cancer care management tools that improve patient quality of life and survival outcomes.
Maniv Mobility is a global venture capital fund investing in the world's leading mobility start-ups.
Show more...Investment focus
- Industry: Automotive, Autonomous Vehicles, Software
- Stage:Series A, Seed, Series B
- Geography: Israel, United States, Mexico
Investor stats
- Total investments: 75
- Round size: Seed $2M–$8M; Series A $4M–$14M; Series B $18M–$126M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $100M in 2019
Portfolio highlights
- Mundimoto — Mundimoto is a motor cycle trading platform.
- NeoLogic (VLSI) — NeoLogic was founded to address the increasing workloads of video, artificial intelligence, machine learning, data analytics, and more in the cloud and at the edge. we developer a unique technology that cuts down the transistor count of circuits by a factor of up to 3x at any technology node.
- Harbinger — Founded by veterans of Canoo and Faraday Future, Harbinger is an automotive company that develops EV platforms optimized for medium-duty trucks and delivery vans.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.
Show more...Investment focus
- Industry: Wellness, Biotechnology, Manufacturing
- Stage:Series A
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Series A $3M–$3.5M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- SolCold — We make the sun cool again - Solcold the new environment solutions
- Trobix Bio — Empowering engineered phages with CRISPR to modify microbiome for better medicine
SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
Show more...Investment focus
- Industry: Pharmaceutical, Cannabis, Biopharma
- Stage:Corporate Round
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Corporate Round $400k–$700k
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
- MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
Ran Tuttnauer
Show more...Investment focus
- Industry: Health Care, Big Data, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Canada, United States
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Innovopro — Bringing a unique chickpea protein platform to the global food & beverage market, for creating nutritious, tasty, and sustainable food products.
- Solidify — The Marketplayz platform helps you find the perfect creators to promote your products. It utilizes AI-powered technology to enable advertisers and creators to connect through a one-stop, self-service marketplace.
- Geneyx — Geneyx offers a superior NGS data analysis and interpretation platform, Harnessing genetic data to guide digital insights for rare and germline disorders Geneyx
PipelBiz enables companies to raise capital from an unlimited number of investors without the need of a prospectus
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Equity Crowdfunding, Seed
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 43
- Round size: Equity Crowdfunding $152k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vootto — Vootto air purifier is renewing its website and will soon return! Breath easy knowing the Vootto will reopen the site shortly
- Omnistream — Our disruptive technology offers professional broadcasters and media enterprises a paradigm shift in engagement. By leveraging the power...
- NeuroSense Therapeutics — NeuroSense Therapeutics Ltd., is a clinical-stage biotechnology company, dedicated to the discovery and development of treatments for debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company's preclinical pipeline includes: (1) StabiliC forthe treatment of Parkinson's disease and (2) CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Aleph is an early stage venture capital fund focused on partnering with great Israeli entrepreneurs to build large, meaningful companies and impactful global brands. Founded in 2013, Aleph is a partnership of Michael Eisenberg, Eden Shochat, Yael Elad and Tomer Diari with $850M under management. Aleph has invested in over 50 companies (not allannounced) including Lemonade, Melio, Healthy.io, SparkBeyond, JoyTunes, Fabric, Freightos and Bringg. Aleph is redefining the kind of support entrepreneurs and the local high tech community can expect from a venture capital firm. We aim to service the hell out of our entrepreneurs with high-touch, partner-level service. We built a startup within our firm - Ampliphy, the Aleph Value Generation Platform - to meet the greatest startup challenges like talent recruitment, business development and follow-on funding - at scale. Ampliphy leverages our people, network, software and resources to help companies succeed on the global stage.The team at Aleph are committed to supporting startups and the entire Israeli tech ecosystem as they harness the power of new technologies to develop and grow transformational companies.
Show more...Investment focus
- Industry: Software, SaaS, Analytics
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, China
Investor stats
- Total investments: 125
- Round size: Seed $2.4M–$13M; Series A $5M–$15M; Series B $10M–$50M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $300M in 2021
Portfolio highlights
- Trullion — The best AI-powered accounting software for lease accounting & revenue recognition compliance. Accountants trust Trullion for automated financial software.
- SphereX — Experience unmatched decentralized security with SphereX, safeguarding your DeFi apps non-stop. Trust in our transparent, ML-based protection.
- Floodlight — Track finances, make smarter decisions, and increase revenue. Think business accounts, cards, payments and cashback, all-in-one.
TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 7
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- SoniVie — SoniVie's lead product, TIVUS, is an investigational intravascular treatment that can be performed as part of a routine right heart catheterization for patients suffering from pulmonary arterial hypertension (PAH)
- SentiAR — SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, "floating" over the patients, with a goal toprovide the clinician and patient a faster, safer delivery of care.SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient.The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.
- Beyeonics — Beyeonics Surgical technologies began operating in 2012, led by a team of Elbit Systems senior engineers with a mission to revolutionize the visualization and information presented during surgery. Future products include visualization systems for other surgical applications as well as solutions for spine surgery, minimal invasive procedures,robotic surgery and use in cardiovascular catheterization labs. Operating from Israel, Beyeonics is working in collaboration with Prof. Anat Lowenstein the Head of Ophthalmic Department and Prof. Adiel Barak the Head of the Retina Department in Tel Aviv Sourasky Medical Center and with Dr. Pravin Dugel managing partner at Retinal Consultants of Arizona.
fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.
Show more...Investment focus
- Industry: Health Care, FinTech, E-Learning
- Stage:Pre-Seed, Seed, Series A
- Geography: Israel, United States, Norway
Investor stats
- Total investments: 19
- Round size: Seed $1.6M–$8M; Pre-Seed $300k–$760k
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Wisor — Propelling the supply chain industry into the digital age Wisor is a plug & play solution that provides a global automated quoting solution that allows freight forwarders to generate quotes and communicate with clients automatically Get a demo What took days now takes minutes Wisor is specifically designed to support and simplify the complexity of generating quotes
- Peech — Peech, an automatic video editing tool, analyzes the verbal content of your video, edits it into a short & catchy version and enhances it with suited visual elements that attract your audience.
- Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series B, Series C
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 49
- Round size: Series B $3M–$23M; Series C $6M–$15M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Append Medical — Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.The Append Medical solution is in the pre-clinical in-vivo trial phase. It is intended to become a differentiated solution in the LAA closure market, which has been estimated to reach $25B within several years. This is the second-fastest growingsegment of the medical device market, with potential sales of $500M in 2019. Append Medical is a member of MEDX Xelerator, a medtech incubator backed by Boston Scientific, Intellectual Ventures, MEDX Ventures and Sheba Medical Center.
- Nectero Medical — Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
- SetPoint Medical — SetPoint Medical is pioneering bioelectronic medicine to develop a safe and cost-effective approach for treatment of chronic autoimmune diseases.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
ZMEP is a limited partnership focusing on equity and equity-like investments in emerging medical device technologies. ZMEP invests globally drawing on the years of investing experience of its management team. With over 50 years of experience in medical device development and commercialization, the ZMEP management team has the ability to seek outand partner with leading entrepreneurs in the medical device field. With offices in the United States and Israel, ZMEP is positioned globally to partner with middle to late stage medical device companies showing great promise for success through commercialization.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Health Care Investor funding in Israel at a glance
Stats across 665 deals from 722 investors.
Access all 722 investors in Israel Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 722 investors investing in Israel Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!